免费文献传递   相关文献

Screening of effective ingredients of Yinzhihuang injection against cholestasis and their mechanism

茵栀黄注射液抗胆汁淤积药效成分的筛选及其作用机制研究



全 文 :2016
y

z à
41
áà

}
Vol41,No.6 March,2016
ŸDË ¡¢e£¤¥¦,‚‘ƒ§¨’“
hifù„…

1,
!ú~
2,
ûè
2,

1
(1
܈Š&?Z …Z…»ZY

܈ ¶Ý
410081;2
UQ?Z WZY

CÃ UQ
315211)

lm
] 
§¨ŸDË ¡¢$ƒÖü,‚‘

TU“ê룤]P¶²ôÔÕ

mڞ%hiƒfù

¨i7–úÎ
ICR

30
÷

‘ò

•

ʸ­\•

5­­\•

ÓÐ]•

D3•

Ë

Í8³•

qu%Ò

%•i¢”¯_
쒣¤]P¶²ôÔՃÜÝ

ÓÐ]•:ˆ¡È
ALT,AST,ALP,TBA
ªÝ‘_ò
(1589±253),(1832±256),
(2638±987)U·L-1,(4063±767)μmol·L-1,D3•:ˆ‘_ò(2054±236),(2428±519),(3509±503)
U·L-1,(4286±711)μmol·L-1,:H°5­­\•(5952±1094),(12837±1797),(16952±962)U·L-1,
(13250±3300)μmol·L-1。%•i¢”‘›ãÿ,ÓÐ]•、D3•:ˆ%ÄŃÌÉ、†–ÄÅa)ûš†5­­
\•ÂÃ:ã䵶

æ¢vö
QPCR
quãÿ

¾.ÓÐ]

D3œ~

£¤]P¶²ôÔÕ
mRNA
ƒ¯_Ã5­­
\•:m°úPŒ–ƒÞá

ŸDË ¡¢$ƒÓÐ]¨D3ÒB‚ÐÑ£¤¥¦

%Ò’%í¢”–—˜
,`
Þá
ANIT
2Zƒ£¤]P¶²ôÔÕ
mRNA
¯_

˜êZr%žhi


nop
] 
ŸDË ¡¢

ÓÐ]

D3

£¤]P¶

%8£¤¥¦

qr)(
] 20150812

stuT
] 
£bø~XZEfij
(81274178,81273582,81302848)

vwAx
] 
!ú~
,Email:liuaiming@nbueducn;

,Email:binguo@hunnuedu

Ax€
] 


ot„uVzz{>7„z„ä.]^
,Email:tanzhen0114@yahoocom
ScreeningofefectiveingredientsofYinzhihuanginjectionagainst
cholestasisandtheirmechanism
TANZhen1,LIUAiming2,LUOMin2,GUOBin1
(1ColegeofChemistryandChemicalEngineering,HunanNormalUniversity,Changsha410081,China;
2MedicalSchoolofNingboUniversity,Ningbo315211,China)
[Abstract] ChineseherbalmedicinalformulationYinzhihuanginjectioniswidelyusedinclinicforjaundiceandchronicliverdisea
sesineasternAsiancountriesHowever,thepharmacologicalyactivecomponentsandtheunderlyingmechanismareunclearInthis
study,30maleICRmicewererandomlyassignedinto6groups:normalcontrol,modelcontrol,chlorogenicacidgroup,geniposide
group,baicalingroupandwogonosidegroupTheliverfunction,liverpathologicalchangesandbileacidmetabolismrelatedgeneex
pressioninmicewereassayedTheserumlevelsofALT,AST,ALP,TBAinchlorogenicacidgroup(1589±253),(1832±
256),(2638±987)U·L-1,(4063±767)μmol·L-1,respectivelyandgeniposidegroup(2054±236),(2428±
519),(3509±503)U·L-1,(4286±711)μmol·L-1,respectivelywerelowerthanthoseinthemodelcontrolgroup
(5952±1094),(12837±1797),(16952±962)U·L-1,(13250±3300)μmol·L-1,respectivelyHematoxylineosin
stainingshowednecrosis,infiltrationofinflammationcelinchlorogenicacidgroupandgeniposidegroupweremilderthanthoseinthe
modelcontrolgroupQPCRanalysisrevealedtheexpressionofbileacidmetabolismrelatedgeneswasnormalizedaftertreatmentwith
chlorogenicacidorgeniposideChlorogenicacidandgeniposideimprovedtheliverinjuryandcholestasisefectively,andreversedthe
mRNAexpressionofbileacidmetabolismrelatedgenesinducedbyANITSo,chlorogenicacidandgeniposidewereprotectiveforcho
·3111·
2016
y

z à
41
áà

}
Vol41,No.6 March,2016
lestasis,suggestingtheirpharmacodynamicefectinYinzhihuanginjection
[Keywords] Yinzhihuanginjection;chlorogenicacid;geniposide;bileacidmetabolism;intrahepaticcholestasis
doi:10.4268/cjcmm20160623
  
ŸDË ¡¢7Ÿ£

D3

×ÚÌ

Ëïö

8$,•

DBÈï

×&

ÁA

á˂¨îHá
’Óƒhi
[14],
åæ45i°œ£¤¥¦

ŸD
Ë ¡¢hò€ù1

7°“³´‘•-

“D,‚‘’,”fùû£Èü

î}

N
Eù•µi
LCMSITTOF
‘›()

ö‰{çú
24
?‘

¹HVvúŸDË ¡¢$ƒ_‘Ë
ï

ÓÐ]

D3

ËïO

ãËï

D3]

&
ÓÐ]

Æ]

Í8³ö
[56]。
“$

Ëï

Ó
Ð]

D3ésöÃ>ƒ•‘

N„…/­
?Öü‘ƒ,‚•–—n§¨

Eyì

FG‘3°‹ƒm‡

­£¤¥¦»
¢ƒ‘3°‹²ôfùƒ„…ˆ—[H!

ë
w„…Ì

‘,°%ÄÅ`¡ç`áՍ
Na+
æý£]aáÕ>ü
(Ntcp)、
BfՕ3áÕ>ü
2(Oatp2)
’£ç`áՍ>,Ø,²ôÑ 

(Mrp2)、
£ªì$Ê
(Bsep)
­£]ª’£ËOƒá
ÕDBÖühi
[79]。
Õ1

­£¤]P¶²ôӒ
áՍƒ„…òœ£¤¥¦ƒ&€;

ÓÐ]韣ƒÖü‘

BΗ£¤‘%¨
Èï×&ö‚

„…më

ÓÐ]­
CCl42Zƒ
%&–B{ポžhi
[10]。
D3hòD3ƒ
Öü‘

­ÁÀ2Zƒ?–%—˜B[vžh
i
[11]。
„…k.Ë‘¼­:ˆ
D
’Ô
|zÅ?–%—˜B[vžhi
[12]。
Í8³
hòŸDË$ƒ‘ð[

ґ@òÒ/
CAR
“
p£ËOȪ¬
[13]。
N(@ò
ANIT
æç%8
£¤¥¦:ˆ/‹5­

„…ŸDË$ƒÖü‘
ÓÐ]

D3

Ëï

Í8³ö­
ANIT
æç
£¤¥¦ƒœhi쒭£¤]P¶²ôáՍ
Ü݃µ¶

ì}˜‘3ªÝôõŸDË$Öü
‘ƒhifù’çè

òÔ°Wâ$,NŸ•–
‘ƒm‡p)”ãÔä

1 
ʸ
α±«]Š³(ANIT,SigmaDE);ÓÐ]、
D3

Ëï

Í8³

$%ͳ,³qv„…
%
);

PCR
¥1
(SYBRGreenPCRMasterMix,
Roche
DE
);

PCR
Á
(LightCycle480,Roche
D
E
);
%ÒBô¥1µ

±m¡¨(¢&(BC
DE
)。
7–úÎ:ˆ
30
÷

Ö
(20±5)g,
µz‡
(/‹$Sp)

úœÌ<
SYXK20130191。
³
B/‹·¥°µz‡(/‹‰
,¸
-Ëv


¬ó–Û¥

ûÍ

ûªÊ¸˜

x£#Òó

oP
(

2 
€ú
21 
/‹(
7–:ˆ
30
÷

Ff‘òʸ­\•


­\•

ÓÐ]•

D3•

Ë

Í8³
•

|•x

÷

ÓÐ]•

D3•

Ë

Í8³•‘_[ŠÓÐ]

D3

Ëï


Í8³
(50mg·kg-1·d-1,
“$

ÓÐ]

Ëï


Í8³#×°¬Qö$

D3#×°°”
ªª$
),
a;
5d。
à

N

5­­\•

ÓÐ]
•

D3•

Ë

Í8³•‘_µi
ANIT


]
(75mg·kg-1),
æm:ˆ?–%
8£¤¥¦¢¯

¤Ox•0̑_[ŠÓÐ
]

D3

Ëï

Í8³

a;
5d,ANIT
[
Š
48h
~³B:ˆIÉ

22 
BNµÀ’ý
 
:ˆ°uZµ¡~
,15mL
•SÀÀ¡¢

`±ÅIÉ

/“»v²I)ƒb

î]51ˆß

/51Kg’Kەi[`îØ

ّJK%í

q
&€%•i

“$%¢{l°
10%
$–²~s°*
*#¢$»v

~}—n¢”q5

“/1‘BV
~†QØ°-9Ý$Qãý


-80℃
Ý
Z±}ý

23 
¡È°_ABqu
:ˆ¡¢°
2000r·min-1
•S
5min
~q¡
È

°_‘›Áuv¡È$
AST(
>aá’Ó
)、ALT

>®á’Ó
)、ALP(
º–Õ]Ó
)、TBA(

¤]
)。
24 
%í¢”%ü
:ˆ%í
10%
$–²~s°**#¢»v
24

~

±ª

Ù(àB

¸ý%ü
,HE
hK

ãXU
,&%í¢”0د_

·4111·
ò 
Žö

ŸDË ¡¢e£¤¥¦,‚‘ƒ§¨’“hifù„…
25 
£¤]P¶²ôÔÕ
mRNA
ÜݪÝuv
251 RNA
pq
 
%í•i$‰
Triol,
Â¥

‘
ò

ËÖ

ùI

߁



pqu
RNA,NanoDrop
2000
uv¿¢š

2

‹u
RNA
ƒZšqu

252 
Þá\Òó
 
q
1μguRNA,‰MMLV
Þá\¥1

E@
PCR
Á$Òó=56
DNA,
°
-20℃
ýSi

253 
æ¢vö
RTPCR
uv
 
56
cDNA1μL,
MasterMix5μL,bO2‹ 02μL,ÛO2‹ 02
μL,DEPCª36μL,•10μLƒõ,æ¢vö
PCR
Á$¯–

áé



Òó
æ¢vö
PCR
ÁÕ/‘›`;=<Ä

“$

($³:;
ƒ2‹¹TÜ
1,
³Bƒ2‹¹T:ì>°2‹
=.4
(htp://mouseprimerdepotncinihgov/)。
Ü
1 
£¤]P¶²ôÔÕ2‹¹T’Æ‹
Table1 Theprimersequencesandproductsofbileacidmetabolismrelatedgenes
ÔÕ bO2‹ ÛO2‹ Ƌ
/bp
Cyp7a1 GTCCGGATATTCAAGGATGC GGGAATGCCATTTACTTGGA 107
Cyp8b1 GATAGGGGAAGAGAGCCACC TCCTCAGGGTGGTACAGGAG 96
Cyp27a1 GGGCACTAGCCAGATTCACA CTATGTGCTGCACTTGCCC 107
Mrp2 TCTGTGAGTGCAAGAGACAGGT TCCAGGACCAAGAGATTTGC 107
Mrp3 CTGCCGGCTAATTCAAATGT TTGTGGAAGAATGTTGCCTC 92
Mrp4 TTAGATGGGCCTCTGGTTCT GCCCACAATTCCAACCTTT 102
Bsep AAGGACAGCCACACCAACTC CCAGAACATGACAAACGGAA 100
Ostb CCAGGACCAGGATGGAATAA AGAGAAAGCTGCAGCCAATG 110
Oatp1 TAATCGGGCCAACAATCTTC ACTCCCATAATGCCCTTGG 109
Oatp2 TAGCTGAATGAGAGGGCTGC ACCAAACTCAGCATCCAAGC 103
18SrRNA ATTGGAGCTGGAATTACCGC CGGCTACCACATCCAAGGAA 102
26 
=.â;
µi
SPSS120
éŒ
、MicrosoftExcel2003
¨
SigmaPlot110
­°_‘›<Ē
QPCR
uv£¤
]P¶²ôÔÕ<ėn‘›
,P<005
Ü{x•
=.ý²±

<ÄDBâ;d

3 

31 
:ˆ¡È%Òqu
 
†Ê¸­\•²Â

(–­\•
ALT
¨
AST
{
ãø
(P<0001),
ãÿ“ý²%Äŗ˜

¤O

ALP¨ TBA
ˆã䏉
(P<0001)。
ê†(–­•ÂÃ

ÓÐ]•†D3•
ALT,AST,ALP
¨
TBA
îH

Ë¨Í8³•ƒ
ALP,ALT,AST
†(
–­\•ðsx{㏱

pÿÓÐ]¨D3Ò²
[vûšb±ù
ANIT
æçƒ%&–

­%8£¤¥
¦B{ãƒ%žhi

êËÍ8³¡°_
‘›<Äãÿ“B{ポžhi

q
1。
32 
%í•i¢”¯_
ʸ•

%í,,

ŸKʸ

%•i¢”,
&

%:{<^Ȇ

%ÄÅå‡ê`

å`Ȇ

Å
¥!G

¹h

q
2A。ANIT
•

5­•
),
%í,,
{ã/—

B‡ü®­ K$ë

%•i¢”,&

B
‡÷¦¢3œ

%:{£È

‡ö†ÄÅa)

ÌÉ{ã

q
2B。
Ë¨Í8³•

IB‡
÷¦¢3œ

¢¯Ç®b=rµ¶

x{ã%ž
hi

q
2C,2D。
ÓÐ]’D3•

$»›œ’
%‘¶šÙ¡

è

3®Ìɼ²‘,

uú†ÄÅa
)

ÌÉ¢3{ãµu

q
2E,2F,2G,2H。
33 
£¤]=²ôÔÕÜ݃µ¶
N($ìæ¢vö
QPCR
quʸ­\•

5­­\•

ÓÐ]•¨D3•:ˆ%í•i£
¤]=²ôÔÕ
mRNA
ƒÜݏ±

5­­•:ˆ%í£¤]=²ôÓ
Cyp7a1,Cyp8b1mR
NA
Ü݆ʸ­\•²Â:ãäîH

ÓÐ]¨
D3•$£¤]=Óƒ
mRNA
Ã5­­\•
ÜÝuÞálʸªÝ

q
3。
pÿÓÐ]¨D
3œÒ@òÐÑ
ANIT
æ烣¤]=Ó
mR
NA
ƒ¯_˜êmÚ%žhi

34 
£¤]áÕ²ôÔÕÜ݃µ¶
%£ÄÅ`²ôáÕÑ BfՕ3áÕ>ü
(Oatp)¨
ñ•3

æý£]*¤áÕ>ü
(NTCP)
ƒ
mRNA
²5­­\•

ÓÐ]•¨D3•$²Â
°Ê¸­\•:ÜÝø

5­­\•$

>,Ø,
·5111·
2016
y

z à
41
áà

}
Vol41,No.6 March,2016
  
†5­­\•²Â
1)P<005,2)P<001,3)P<0001,ns
xâ;d

q
3,4
¤
)。
q
1 
x•:ˆ%íÒƒ¯_
Fig1 Changesofliverfunctionsinmiceserumfromeachgroup
A
ʸ•
;B
5­­\•
;C
Ë
;D
Í8³•
;E
ÓÐ]•
(40
¦
);F
ÓÐ]•
(400
¦
);G
D3•
(40
¦
);H
D3•
(400
¦
)。
q
2 
x•:ˆ%í•i¢”%ü<Ä
(HE
hK

’VAÿ†–ÄÅa)

Fig2 ResultsofHEstainingformiceliversectionineachgroup(HEstaining,arowsindicatetheinfiltrationofinflammatorycel)
²ôÑ 
Mrp2,Mrp3,Mrp4¨
ñŠ‹–£ªáՍ
Ostb
ƒ
mRNA
ÜÝÃʸ­\•ø

¾.ÓÐ
]

D3œ~

:$ëîH

q
4。
ù{ÓÐ
]¨D3­
Mrp2,Mrp3,Mrp4
ì’
OstbmRNA
Ü
ݪ݃ÞáhiœÒé0m°
ANIT
ƒ&–Ò
ó

˜êmÚ%žhi

åbœ¶

£¤]8P
¶é[-ƒòû

àB£¤]ƒ=

Öíq’
S±òû

N($£¤]P¶òû$²ôáՍ
ƒ¯_Ôgq
5,
ù{ÓÐ]†D3²[vû
šb±ùú
ANIT
­áՍƒÐ¯

˜ê±ù
ANIT
³æçƒ%&–

Zr%흞hi

4 
õã
ANIT
é[?_‹´

Õ
1952
y[X†%æ
ü!]i¯ù$%8£¤¥¦5­ìì

u45
ói°%8£¤¥¦5­ƒù
。ANIT
hò[?
sè%&1

Öü—É%8£bKÄÅ

2Z%
·6111·
ò 
Žö

ŸDË ¡¢e£¤¥¦,‚‘ƒ§¨’“hifù„…
   
q
3 
x•:ˆ%í•i£¤]=Ó
mRNA
ƒÜݯ_
Fig3 ModificationofmRNAexpressionsinvolvedinbileacid
synthesisinmicelivers
q
4 
x•:ˆ%í•i£¤]áÕ²ôÔÕ
mRNA
Ć
ݯ_
Fig4 ModificationofmRNAexpressionsinvolvedinbileacid
transportinmicelivers
8£°’:{s£±P†Ç

˜ê£
WP

0{ャ¤¥¦
,`
¼Bìè®ÌÉòÖ
ƒ%´ÄŗÉ

Æ°£¤¥¦–Ë‚

$됣
ËO¡Ç¨£¤‘%îH

¤Oê2Z`W´òt
_Òó

÷X%Äů–ÌÉ

Å8
ALT
‡ö“
¡®

ñ5­ù™—tn

Ö–$

駨¨„
…%,‹’Á£,ƒ”d(/‹5­
[14]。
£¤]ƒP¶àB£¤]=

áÕ¨S±

£¤]ƒÐ¸ò£»Ê

?ò[õTƒÓÎÒó

0
£¤]

£¤]B

?=èé
[15],
?mèé
  
S’V¨öS’V‘_PÜ(–5­•

ÓÐ]•

D3•£¤
]P¶²ôÔÕ
mRNA
Üݪ݃¯_

q
5 
%ÄÅ$£¤]ƒ=¨P¶q
Fig5 Thediagramofhepatocytesbileacidsynthesisandme
tabolism
飤]=ƒÖüèé

?mèé7£»Ê
7α
·_Ó
(cholesterol7αhydroxylase,CYP7A1)È/,
CYP7A1
é1ÒóƒCQÓ

£¤]=ƒr[
èé¦òVPèé

7ŒÊ
27α·_Ó(CYP27A1)
¨ŒÊ
12α·_Ó(CYP7B1)È/,7¦°’±
t£]

„…k.¦
ANIT
9:~+æç
SHPmR
NA
Ü݃‰
,SHP
†
LRH1
0ƒ8š+±
ù
Cyp7α1,Cyp8b1ƒÜÝ[1618]。N„…$,ANIT
æç%8£¤¥¦~

£¤]=Ó²ôÔÕÜÝ
:îH

¾.ÓÐ]¨D3œ~ÜÝÞrÊ
¸ªÝ

¤‚
,ANIT
æç~

£¤]ÖíqáՍ
Oatps¨ NtcpmRNA
ÜÝîH

ÓÐ]¨D3œ
~Þʸ
。Chisholm
ƒ„…A$
HNF1α²ê
ëÖíqáՍ$mÚúÖühi
,ANIT
îH
HNF1αì’áՍ Oatps¨ Ntcpƒ mRNAÜ
Ý
[19]。
ìb„…ù{

ÓÐ]¨D3œì˜[v
ûšbPŒ–Þá
ANIT
³2Zƒ£¤]=Óƒ
îH

²
ANIT
³æ烣¤¥¦5­$

B„…m
ë‡ËO­
ANIT
³2Zƒ£¤¥¦­%†B$ƒ
žhi

“$

‡ËOÖü@ò±ùΆÕ3

t
_óҗ˜ömÚhi
[20]。
$,ù1mµüˆÒ
@òÐÑt_óÒ쒱ù$–½ÄÅa)öèé
Zr%žhi
[21]。
²W>Å
(LPS)
æçƒ
C56/
BL6
:ˆ?–%—˜5­$

¾,
50mg·kg-1
ÓÐ
]~

%íŸK7ËKÞòʸƒ¹ËK
,ALT,
AST
ªÝãäîH

9@ò:B¾,ÓÐ]
,TLR4,
·7111·
2016
y

z à
41
áà

}
Vol41,No.6 March,2016
TNFα,NFκBö†ÇÔÕ mRNAÜݪÝB³î
H

pÿÓÐ]œÒ@òe†fù­
LPS
æçƒ%
&–Zržhi
[22]。
²D3žÁÀ–%—
˜ƒ„…$

et_Ó
GSH,GST,GPx,CuZnSOD
¨
CAT
ƒ•–bê

t_óÒ%—˜{ãÐÑ
[11]。
N
„…$

¢”‘›ãÿ5­­\•$:ˆ%íB
‡÷¦¢3œ

%:{£È

‡ö†ÄÅa
)

ÓÐ]¨D3•$†–ÄÅa){ãµu

Õ1

ÓÐ]¨D3éç@ò±ù†Ç@N˜ê
ë­
ANIT
æ烣¤¥¦¨?–%—˜Zr%
흞hi

Bžü­“fù—ný‰!ƒú×

òNŸ,‹ƒåæóip)&=”ƒ”ãŠ.


yg?z

[1] 
–QL

–”.

£X

ŸDË ¡¢%hiƒ(„…
[J]
$%,&‡k
,2001,32(6):440
[2] 
ÿ±E

y$•



ŸD˚½œ?–Ë‚­%†ƒ
‚,&
[J]
K1A
,2010,22(8):1497
[3] 
ÀwH

K¿Ñ

ÕÙÙ

ŸD˚½ƒ%hi„…
[J]
$,Ê
,2001,24(5):353
[4] 


—t.

²¾¢

ŸD˚½ƒ?–&–¨%h
i„…
[J]
a{,h
,2004,23(6):49
[5] 
•r

ŸDË ¡¢ƒ_A€’P¶L„…
[D]
±m

‘9…O‡
,2014
[6] ZengL,WangM,YuanY,etalSimultaneousmulticomponent
quantitationofChineseherbalinjectionYinzhihuanginratplas
mabyusingasingletubeextractionprocedureformassspectrom
etrybasedpharmacokineticmeasurement[J]JChromatogrB
AnalytTechnolBiomedLifeSci,2014,967:245
[7] AreseM,AnanthananarayananM,SuchyFJHepatobiliarytrans
port:molecularmechanismsofdevelopmentandcholestasis[J]Pe
diatrRes,1998,44(2):141
[8] MeierPJ,StiegerBBilesalttransporters[J]AnnuRevPhysi
ol,2002,64(4):635
[9] AreseM,TraunerMMolecularaspectsofbileformationand
cholestasis[J]TrendsMolMed,2003,9(12):558
[10] ShiH,DongL,BaiY,etalChlorogenicacidagainstcarbon
tetrachlorideinducedliverfibrosisinrats[J]EurJPharmacol,
2009,623(1/3):119
[11] WangJ,ZhangY,LiuR,etalGeniposideprotectsagainst
acutealcoholinducedliverinjuryinmiceviaupregulatingthe
expressionofthemainantioxidantenzymes[J]CanJPhysiol
Pharmacol,2015,93(4):261
[12] 
Í2

ɍ

˻

ö

Ë‘¼­:ˆ
D
’Ô|z
Å?–%—˜ƒžhi
[J]
$%$KA<=-.
,2014,
34(1):71
[13] WendongHuang,JunZhang,DavidDMooreAtraditionalherbal
medicineenhancesbilirubinclearancebyactivatingthenuclearre
ceptorCAR[J]JClinInvest,2004,113(1):137
[14] 
!\Å

–“

–þ

áË=1­
ANIT
æm%8£¤¥¦
‡ˆƒµ¶
[J]
$%$A,v-.
,2004,11(12):
1052
[15] CrosignaniA,DelPuppoM,LongoM,etalChangesinclassic
andalternativepathwaysofbileacidsynthesisinchronicliver
disease[J]ClinChimActa,2007,382(1/2):82
[16] delCastiloOlivaresA,GilGSuppressionofsterol12alpha
hydroxylasetranscriptionbytheshortheterodimerpartner:in
sightsintotherepressionmechanism[J]NucleicAcidsRes,
2001,29(19):4035
[17] DensonLA,SturmE,EchevariaW,etalTheorphannuclear
receptor,shp,mediatesbileacidinducedinhibitionoftherat
bileacidtransporter,ntcp[J]Gastroenterology,2001,121
(1):140
[18] TanakaY,AleksunesLM,CuiYJ,etalANITinducedintra
hepaticcholestasisaltershepatobiliarytransporterexpressionvia
Nrf2dependentandindependentsignaling[J]ToxicolSci,
2009,108(2):247
[19] ChisholmJW,NationP,DolphinPJ,etalHighplasmacho
lesterolindruginducedcholestasisisassociatedwithenhanced
hepaticcholesterolsynthesis[J]AmJPhysiol,1999,276
(5Pt1):G1165
[20] DingY,ZhaoL,MeiH,etalExplorationofemodintotreatal
phanaphthylisothiocyanateinducedcholestatichepatitisviaanti
inflammatorypathway[J]EurJPharmacol,2008,590(1/3):
377
[21] DingLL,ZhangBF,DouW,etalProtectiveefectofDan
ningtabletonacuteliveryinjurywithcholestasisinducedbyal
phanaphthylisothiocyanateinrats[J]JEthnopharmacol,2012,
140(2):222
[22] XuYuexin,ChenJingwen,YuXiao,etalProtectiveefectsof
chlorogenicacidonacutehepatotoxicityinducedbylipopolysac
charideinmice[J]InflammRes,2010,59(10):871

{|-0
 
}~~

·8111·